Literature DB >> 31050087

Functional classification of ATM variants in ataxia-telangiectasia patients.

Alice Fiévet1,2, Dorine Bellanger1, Guillaume Rieunier1, Catherine Dubois d'Enghien2, Julia Sophie3, Patrick Calvas3, Jean-Paul Carriere4, Mathieu Anheim5, Anna Castrioto6, Olivier Flabeau7, Bertrand Degos8, Claire Ewenczyk9, Nizar Mahlaoui10, Fabien Touzot10, Felipe Suarez11, Marie Hully12, Agathe Roubertie13, Nathalie Aladjidi14, François Tison15, Hélène Antoine-Poirel16, Karine Dahan16, Diane Doummar17, Marie-Christine Nougues18, Christine Ioos19, Christelle Rougeot20, Alice Masurel21, Caroline Bourjault22, Emmanuelle Ginglinger23, Fabienne Prieur24, Aurélie Siri25, Pierre Bordigoni26, Karine Nguyen27, Noel Philippe28, Céline Bellesme29, François Demeocq30, Cecilia Altuzarra31, Michèle Mathieu-Dramard32, Fanny Couderc33, Thilo Dörk34, Nathalie Auger35, Béatrice Parfait36, Khadija Abidallah2, Virginie Moncoutier2, Agnès Collet2, Dominique Stoppa-Lyonnet1,2,37, Marc-Henri Stern1,2.   

Abstract

Ataxia-telangiectasia (A-T) is a recessive disorder caused by biallelic pathogenic variants of ataxia-telangiectasia mutated (ATM). This disease is characterized by progressive ataxia, telangiectasia, immune deficiency, predisposition to malignancies, and radiosensitivity. However, hypomorphic variants may be discovered associated with very atypical phenotypes, raising the importance of evaluating their pathogenic effects. In this study, multiple functional analyses were performed on lymphoblastoid cell lines from 36 patients, comprising 49 ATM variants, 24 being of uncertain significance. Thirteen patients with atypical phenotype and presumably hypomorphic variants were of particular interest to test strength of functional analyses and to highlight discrepancies with typical patients. Western-blot combined with transcript analyses allowed the identification of one missing variant, confirmed suspected splice defects and revealed unsuspected minor transcripts. Subcellular localization analyses confirmed the low level and abnormal cytoplasmic localization of ATM for most A-T cell lines. Interestingly, atypical patients had lower kinase defect and less altered cell-cycle distribution after genotoxic stress than typical patients. In conclusion, this study demonstrated the pathogenic effects of the 49 variants, highlighted the strength of KAP1 phosphorylation test for pathogenicity assessment and allowed the establishment of the Ataxia-TeLangiectasia Atypical Score to predict atypical phenotype. Altogether, we propose strategies for ATM variant detection and classification.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  ataxia-telangiectasia; ataxia-telangiectasia mutated (ATM); checkpoint; mutation; phenotype; splice

Mesh:

Substances:

Year:  2019        PMID: 31050087     DOI: 10.1002/humu.23778

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

1.  DNA methylation and gene expression signatures are associated with ataxia-telangiectasia phenotype.

Authors:  Sharon A McGrath-Morrow; Roland Ndeh; Kathryn A Helmin; Basil Khuder; Cynthia Rothblum-Oviatt; Joseph M Collaco; Jennifer Wright; Paul A Reyfman; Howard M Lederman; Benjamin D Singer
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

2.  Management of a pediatric patient with ataxia telangiectasia: Report of a rare case in which diagnostic radiographs are contraindicated.

Authors:  Mebin George Mathew
Journal:  J Family Med Prim Care       Date:  2020-02-28

3.  Elevated inflammatory responses and targeted therapeutic intervention in a preclinical mouse model of ataxia-telangiectasia lung disease.

Authors:  Rudel A Saunders; Thomas F Michniacki; Courtney Hames; Hilary A Moale; Carol Wilke; Molly E Kuo; Johnathan Nguyen; Andrea J Hartlerode; Bethany B Moore; JoAnn M Sekiguchi
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

4.  Six Novel ATM Gene Variants in Sri Lankan Patients with Ataxia Telangiectasia.

Authors:  D Hettiarachchi; Hetalkumar Panchal; B A P S Pathirana; P D Rathnayaka; A Padeniya; P S Lai; V H W Dissanayake
Journal:  Case Rep Genet       Date:  2020-12-09

5.  Atypical Ataxia Presentation in Variant Ataxia Telangiectasia: Iranian Case-Series and Review of the Literature.

Authors:  Tannaz Moeini Shad; Reza Yazdani; Parisa Amirifar; Samaneh Delavari; Marzieh Heidarzadeh Arani; Seyed Alireza Mahdaviani; Mahnaz Sadeghi-Shabestari; Asghar Aghamohammadi; Nima Rezaei; Hassan Abolhassani
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

6.  Unusual clinical manifestations and predominant stopgain ATM gene variants in a single centre cohort of ataxia telangiectasia from North India.

Authors:  Amit Rawat; Rahul Tyagi; Himanshi Chaudhary; Vignesh Pandiarajan; Ankur Kumar Jindal; Deepti Suri; Anju Gupta; Madhubala Sharma; Kanika Arora; Amanjit Bal; Priyanka Madaan; Lokesh Saini; Jitendra Kumar Sahu; Yumi Ogura; Tamaki Kato; Kohsuke Imai; Shigeaki Nonoyama; Surjit Singh
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

7.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.